Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 41

Trial Status

Completed2
Other1

Role Distribution

Principal Investigator3
PI Rate100%

Activity Timeline

Clinical Trials (3)

NCT04401215Not ApplicableCompleted
Technologically-Augmented Referrals to Mitigate Addiction Consequences
Substance Use Disorders
PrincipalinvestigatorStart date: 2019-09-23
NCT03168451Not ApplicableCompleted
American Indians STOp Smoking by Mobile Phone
Tobacco Use Cessation
PrincipalinvestigatorStart date: 2015-11-30
NCT04382625Phase 4Withdrawn
Hydroxychloroquine in SARS-CoV-2 (COVID-19) Pneumonia Trial
COVID-19SARS-CoV-2 Pneumonia
Principalinvestigator

Research Network

Collaboration Network

5 collaborators·7 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Washington State University

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Sean Cook, D.O.

Kootenai Health

Related
1 trials

Shared therapeutic areas:

COVID-19SARS-CoV-2 PNEUMONIA

Worked with same sponsors:

Kootenai HealthWashington State University
Collaborated on 1 trial
Similarity Score24%

Jeanette Berg, MD, PhD

Kootenai Health

Related
1 trials

Shared therapeutic areas:

COVID-19SARS-CoV-2 PNEUMONIA

Worked with same sponsors:

Kootenai HealthWashington State University
Collaborated on 1 trial
Similarity Score24%

John Roll, PhD

Washington State University

Related
1 trials

Shared therapeutic areas:

COVID-19SARS-CoV-2 PNEUMONIA

Worked with same sponsors:

Kootenai HealthWashington State University
Collaborated on 1 trial
Similarity Score24%

Zev Schuman-Olivier, MD

Cambridge Health Alliance

Related
14 trials

Shared therapeutic areas:

COVID-19Substance Use Disorders
Similarity Score15%

Dedra Buchwald, MD

Washington State University

Related
1 trials

Shared therapeutic areas:

Tobacco Use Cessation

Worked with same sponsors:

Optum, Inc.Washington State University
Collaborated on 1 trial
Similarity Score14%

Xiaolong Qi, MD

LanZhou University

Related
8 trials

Shared therapeutic areas:

COVID-19
Similarity Score8%

Sabine Hazan, MD

ProgenaBiome

Related
41 trials

Shared therapeutic areas:

COVID-19
Similarity Score8%

Toshimitsu Tokimoto

Astrazeneca KK

Related
16 trials

Shared therapeutic areas:

COVID-19
Similarity Score8%

Madhukar Trivedi, MD

University of Texas Southwestern Medical Center

Related
13 trials

Shared therapeutic areas:

Substance Use Disorders

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)
Similarity Score8%

Wenhong Zhang, MD

Huashan Hospital

Related
4 trials

Shared therapeutic areas:

COVID-19
Similarity Score8%

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT04401215Not ApplicablePrincipalInvestigator

Technologically-Augmented Referrals to Mitigate Addiction Consequences

Substance Use Disorders
Completed
NCT03168451Not ApplicablePrincipalInvestigator

American Indians STOp Smoking by Mobile Phone

Tobacco Use Cessation
Completed
NCT04382625Phase 4PrincipalInvestigator

Hydroxychloroquine in SARS-CoV-2 (COVID-19) Pneumonia Trial

COVID-19SARS-CoV-2 Pneumonia
Withdrawn

All 3 trials loaded